hepatocellular-carcinoma

Documents about hepatocellular-carcinoma

• Atractylenolide I stabilizes HMOX1 to induce ferroptosis and enhance lenvatinib efficacy in hepatocellular carcinoma.#615921NCBI PubMed Central
• SLC25A45 as a prognostic biomarker promotes malignant progression via mutant p53 in hepatocellular carcinoma.#666083NCBI PubMed Central
• Sex Hormone Receptors, HBV Integrations and Their Prognostic Predictive Value Among Hepatocellular Carcinoma Patients.#671064NCBI PubMed Central
• Combine TACE and RFA Versus TACE Alone for HCC With PVTT#829396ClinicalTrials.gov
• Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma#831570ClinicalTrials.gov
• Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation#860249ClinicalTrials.gov
• Postoperative Adjuvant TACE Treatment in CK18 Positive Patients#861973ClinicalTrials.gov
• Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer#867331ClinicalTrials.gov
• Liver Cancer Disparities in American Indian and Alaska Native Persons#871577ClinicalTrials.gov
• Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer#881732ClinicalTrials.gov
• A Study of PTX-9908 Injection for Non-resectable HCC with TACE#906568ClinicalTrials.gov
• Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors#136314ClinicalTrials.gov
• Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients#801860ClinicalTrials.gov
• Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial#888848ClinicalTrials.gov
• Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer#886466ClinicalTrials.gov
• Radiomics and blood biomarkers for predicting efficacy of sintilimab plus lenvatinib in advanced hepatocellular carcinoma.#4455NCBI PubMed Central
• Cost-effectiveness analysis of toripalimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma.#9429NCBI PubMed Central
• miR-370 regulates ISG15 expression and influences IFN- [Formula: see text] sensitivity in hepatocellular carcinoma cells#147354PMC Full-Text (OAI)
• WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy#154650ClinicalTrials.gov
• Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy#158206ClinicalTrials.gov
• Identification of DYNLL1 and FGFR2 as potential apoptosis-associated biomarkers in HBV-related hepatocellular carcinoma.#170612NCBI PubMed Central
• INVESTIGATING THE ROLE OF INNATE LYMPHOID CELLS AND Tc17 IN HUMAN HEPATOCELLULAR CARCINOMA#258473ScholarBank@NUS
• Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies#290946ClinicalTrials.gov
• A Novel Predictive Model Based on Glutathione Metabolism Genes RRM2 and G6PD in Hepatocellular Carcinoma.#298823NCBI PubMed Central
• NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors#314341ClinicalTrials.gov
• Cross-etiology transcriptomic conservation in hepatocellular carcinoma reveals opposing proliferation and hepatocyte-loss programs validated across cohorts#325020bioRxiv / medRxiv
• Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Guidance#353098arXiv CS
• Air pollution and hepatocellular carcinoma: Integrated network toxicology, machine learning, molecular docking and multiomics analysis.#358280NCBI PubMed Central
• Mining and experimental validation of machine learning-based immune-related diagnostic biomarkers for hepatocellular carcinoma.#360648NCBI PubMed Central
• Hepatocellular carcinoma metastasis to salivary glands: a systematic review of diagnostic challenges and survival outcomes.#360760NCBI PubMed Central
• Identification of telomere-related gene signatures for immune cell infiltration and prognosis in hepatocellular carcinoma.#368069NCBI PubMed Central
• Scientific, regulatory, and practical considerations for bringing hepatocellular carcinoma biomarkers into clinical practice.#382554NCBI PubMed Central
• Radiotherapy and Immunotherapy In Hepatocellular Carcinoma: Priming the Tumor Immune Microenvironment From Bench To Bedside.#402595NCBI PubMed Central
• Cumulative Metformin Use and Hepatocellular Carcinoma Risk After HCV SVR: A Multicentre Cohort Study.#404357NCBI PubMed Central
• CACUL1 promotes hepatocellular carcinoma progression through enhanced tumor cell proliferation and macrophage-mediated immune suppression.#418422NCBI PubMed Central
• Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC#432871ClinicalTrials.gov
• Palmitoylation-related gene signature for immune subtyping, prognostic stratification, and immunotherapy guidance in hepatocellular carcinoma.#452883NCBI PubMed Central
• Perioperative gut microbial ecology: a new frontier for improving the prognosis of hepatocellular carcinoma surgery.#469131NCBI PubMed Central
• Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer#481770ClinicalTrials.gov
• A Validated, explainable machine learning-based preoperative risk model for microvascular invasion in hepatocellular carcinoma.#615736NCBI PubMed Central
• Advances in galactose-based small-molecule hepatocyte-targeting probes for detecting biomarkers in hepatocellular carcinoma.#653353NCBI PubMed Central
• Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies#804621ClinicalTrials.gov
• Hepatic stellate cells promote structural and functional remodeling of three-dimensional hepatocellular carcinoma coculture spheroids.#823556NCBI PubMed Central
• HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT#839346ClinicalTrials.gov
• Trans-arterial Chemoembolization in Patients With Hepatocellular Carcinoma: A Study of Different Outcomes and Their Predictive Factors#841752ClinicalTrials.gov
• A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations#853752ClinicalTrials.gov
• RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC#858865ClinicalTrials.gov
• A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer#883996ClinicalTrials.gov
• TACE Combined With Lenvatinib and Sintilimab for Advanced HCC#888294ClinicalTrials.gov
• Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver Cancer#895826ClinicalTrials.gov